Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about XNAS:LEXXW

Recent news which mentions XNAS:LEXXW

Positive Partial 12-Week Blood Sugar Results from Lexaria's GLP-1 Diabetes Animal Study
Tickers LEXX
Tags Lexaria Bioscience Corp/ XNAS:LEXXW XNAS:LEXX
From TheNewswire.com - RSS (Media)
Positive Partial 12-Week Body Weight Results from Lexaria's GLP-1 Diabetes Animal Study
Tickers LEXX TEVA
Tags XNAS:LEXXW XNAS:LEXX Lexaria Bioscience Corp/
From TheNewswire.com - RSS (Media)
Lexaria Announces Closing of $5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Tickers LEXX
Tags XNAS:LEXXW XNAS:LEXX Lexaria Bioscience Corp/
From TheNewswire.com - RSS (Media)
Lexaria Awarded New Patents
Tickers LEXX
Tags XNAS:LEXXW XNAS:LEXX Lexaria Bioscience Corp/
From TheNewswire.com - RSS (Media)
Premier Wellness Science Launches New Brand in Preparation to Deploy DehydraTECH CBD Products in Japan
Tags Lexaria Bioscience Corp/ XNAS:LEXXW XNAS:LEXX
From TheNewswire.com - RSS (Media)
Lexaria Enters One-Year Media Outreach Agreement with SRAX, Inc.
Tickers LEXX LEXXW SRAX
Tags XNAS:LEXXW XNAS:LEXX Lexaria Bioscience Corp/
From TheNewswire.com - RSS (Media)
Lexaria's DehydraTECH-CBD Lowers Blood Pressure
Tickers LEXX LEXXW
Tags XNAS:LEXX XNAS:LEXXW
From TheNewswire.com - RSS (Media)
DehydraTECH(TM) - Enabled Consumer Products Now Available in Over 7,000 Stores
Tickers LEXX LEXXW TM
Tags XNAS:LEXX XNAS:LEXXW
From TheNewswire.com - RSS (Media)
Lexaria Completes Dosing in Human Clinical Study HYPER-H21-2
Tickers LEXX LEXXW
Tags XNAS:LEXXW XNAS:LEXX
From TheNewswire.com - RSS (Media)
Lexaria Receives US$3,817,643 From Warrant Exercises
Tickers LEXX LEXXW
Tags XNAS:LEXX XNAS:LEXXW
From TheNewswire.com - RSS (Media)
Lexaria Summarizes Successful Antiviral Drug Studies and Ongoing Strategy
Tickers LEXX LEXXW
Tags XNAS:LEXXW XNAS:LEXX
From TheNewswire.com - RSS (Media)
Lexaria's DehydraTECH Significantly Enhances Delivery of Colchicine in Study VIRAL-A20-3
Tickers LEXX LEXXW
Tags XNAS:LEXX XNAS:LEXXW
From TheNewswire.com - RSS (Media)
Lexaria Completes Successful Antiviral Drug Molecular Characterization Study with Canada's National Research Council
Tickers LEXX LEXXW
Tags XNAS:LEXX XNAS:LEXXW
From TheNewswire.com - RSS (Media)
Lexaria Receives Patent Protection in Japan
Tickers LEXX LEXXW
Tags XNAS:LEXXW XNAS:LEXX
From TheNewswire.com - RSS (Media)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.